Munzarová M, Kovarík J, Ptácková B, Hlávková J, Kolcová V, Nebeský T
Neoplasma. 1984;31(1):95-8.
DNCB and PPD skin testing was performed in 130 breast and 110 cervical cancer patients. BATES' instruction with a plea for uniformity was used [1]. Patients were tested while being diagnosed and prior to the treatment. No significant differences either in the frequency of a reactivity or grade of response in corresponding stages of breast and cervical cancer were found.
对130例乳腺癌患者和110例宫颈癌患者进行了二硝基氯苯(DNCB)和结核菌素纯蛋白衍生物(PPD)皮肤试验。采用了BATES的指导意见并呼吁保持一致性[1]。在患者诊断期间及治疗前进行了检测。未发现乳腺癌和宫颈癌相应阶段的反应频率或反应分级有显著差异。